Monday
09:00 - 15:35
Joslin Hall

Industry Symposium Novo Nordisk A/S (full day)

ADVANCING INSULIN INNOVATION FOR PEOPLE WITH DIABETES

John Cunningham
Welcome and introduction
Athena Philis-Tsimikas, Lena Landstedt-Hallin
Why should hypoglycaemia be a compromise?
Liana Billings
Durability of a dual appr oach
Steven Bain
Intensified insulin management around mealtimes
Athena Philis-Tsimikas, Lena Landstedt-Hallin, Liana Billings, Steven Bain
Practical steps for insulin intensification
Richard Bergenstal (USA)
Keynote: Glucose management beyond HbA1c

OPTIMISING THE USE OF GLP-1RAS IN PEOPLE WITH TYPE 2 DIABETES

John Cunningham
Welcome back
Subodh Verma
Clinical implications of evidence from cardiovascular outcomes trials
Rory McCrimmon
Treatment intensification with semaglutide OW
Marc Evans
Real-world evidence in type 2 diabetes care
Subodh Verma, Rory McCrimmon, Marc Evans
Clinical aspects of use of GLP-1RAs

OPTIMISING THE USE OF GLP-1RAS IN PEOPLE WITH OBESITY

John Cunningham
Welcome back
Thomas Wadden
Is there a role for IBT in weight management?
Ofri Mosenzon
Weight management in people with type 2 diabetes on insulin
Thomas Wadden, Ofri Mosenzon
Integrating weight management into type 2 diabetes care

FUTURE PERSPECTIVES FOR TYPE 2 DIABETES CARE

John Cunningham
Welcome back
Melanie Davies
Oral GLP-1RAs – a new approach to diabetes treatment*
Vanita Aroda
Evaluating clinical r elevance of an oral GLP-1RA in different populations
Melanie Davies, Vanita Aroda
Patient-centered decision making
John Cunningham
Close of the day
Symposia by: